IRIS
PAOLINO, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.541
Totale 9.541
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.541
Totale 9.541
Salva come PNG Salva come JPEG
Città #
Genova 6.506
Genoa 1.294
Rapallo 1.038
Vado Ligure 656
Bordighera 47
Totale 9.541
Salva come PNG Salva come JPEG
Nome #
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 162
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 152
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 149
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 146
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 142
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 137
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 135
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 134
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 134
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 133
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 129
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 125
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 123
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 121
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 121
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 120
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 115
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 113
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 113
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 113
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 112
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 111
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 111
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 110
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 110
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 109
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 109
Vitamin D in rheumatoid arthritis. 109
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 108
Vitamin D, steroid hormones, and autoimmunity. 107
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 107
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 107
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 106
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 106
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. 105
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey 103
Correlation between bone quality and microvascular damage in systemic sclerosis patients 102
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 101
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 100
Systemic lupus erythematosus: state of the art on clinical practice guidelines 100
A method for counting monosodium urate crystals in synovial fluid 99
Anti-TNF and sex hormones 98
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 98
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 95
Advanced in naifold capillaroscopic analysis in systemic sclerosis 95
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 93
RHEUMATOID VERSUS PSORIATIC ARTHRITIS: SIMILAR OR DIFFERENT BONE LOSS? 93
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 92
PLASMA VITAMIN D LEVELS IN RELATION TO INSULIN RESISTANCE AND RISK OF METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS PATIENTS 90
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. 89
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 88
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 88
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 87
Osteoporosis in the elderly. 87
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. 86
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 84
Use of glucocorticoids and risk of infections. 83
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 82
New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review 81
Capillaroscopy 2016: new perspectives in systemic sclerosis. 80
Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques. 80
VITAMIN D SERUM LEVELS CORRELATE WITH BONE MASS VALUES IN POSTMENOPAUSAL SYSTEMIC SCLEROSIS PATIENTS 79
Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. 79
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 79
[Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis]. 78
Are there any positive effects of TNF-alpha blockers on bone metabolism? 78
Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. 78
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. 77
Comment on: Lower urinary tract symptoms in systemic sclerosis patients: a detailed investigation: reply. 77
Role of endothelin-1 on cell growth and fibrogenesis by primari cultures of human fibroblast: the effects of sex hormones 75
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 74
Vitamin D, inflammation and immunity: review of literature and considerations on recent translational and clinical research developments 74
Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases 73
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 69
Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study. 69
The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients. 64
Systemic sclerosis: markers and targeted treatments 63
Plasma cortisol and cholesterol differently correlate with disease activity in a pilot group of rheumatoid arthritis patients 63
The preliminary validation of laser Doppler flowmetry in systemic sclerosis in accordance with the OMERACT filter: A systematic review. 60
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 59
Naifold capillaroscopy in rheumatology: ready for the daily use but with care in terminology 57
Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis. 56
Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. 56
Assessment of the plantar pressure and its correlation with the disease progression in patients with rheumatoid arthritis | [Valutazione della pressione plantare e correlazione con l'attività di malattia nei pazienti con artrite reumatoide] 55
Effects of anti-TNFα treatment on lipid profile in patients with active rheumatoid arthrits 55
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study 55
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 55
The paradox of ankylosing spondylitis: Concomitant osteoporosis and new bone formation 54
Influence of anti-TNF alpha treatment on insulin resistance in patients with active rheumatoid arthritis. 54
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients. 54
Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects. 53
Nutritional Status and Bone Microarchitecture in a Cohort of Systemic Sclerosis Patients 53
Epigenetics, pregnancy and autoimmune rheumatic diseases. 53
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis 51
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 51
Undifferentiated connective tissue disease: state of the art on clinical practice guidelines 47
Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study 47
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 43
Apremilast interferes with the TGFβ1-induced transition of human skin fibroblasts into profibrotic myofibroblasts: in vitro study 42
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system. 41
Totale 9.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.280
article - articoli 34.741
book - libri 0
conference - conferenze 1.260
curatela - curatele 0
other - altro 135
patent - brevetti 0
selected - selezionate 0
volume - volumi 144
Totale 72.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.249 0 0 0 0 221 334 346 227 251 455 343 72
2020/20211.111 60 104 126 106 83 88 53 93 84 130 83 101
2021/20221.422 60 69 83 164 39 97 111 332 111 122 70 164
2022/20231.282 144 93 27 90 196 173 21 105 207 25 175 26
2023/20241.096 35 125 17 129 51 204 77 115 37 34 68 204
2024/2025758 135 208 104 186 125 0 0 0 0 0 0 0
Totale 10.027